[1] |
JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin .
Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
|
[2] |
WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei.
Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
|
[3] |
CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng.
Trend of mortality and disease burden of gastric cancer in China,2004—2021
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
|
[4] |
GUO Zhiyu, CAO Tianyu, WANG Weidong, GUO Xingxian, MA Wanqi, LU Yuanyuan, ZHAO Xiaodi, JI Gang.
Correlation between blood lipid levels and survival prognosis of gastric cancer patients under operation: A retrospective cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 687-693.
|
[5] |
XUAN Wenzhen, GONG Jianmin, LI Na.
Incidence,mortality,and disease burden of cervical cancer in China,1990—2021: trends over the past 30 years and future prediction
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 694-700.
|
[6] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[7] |
SU Xin, FAN Wenyi, XU Xinye, XU Xuedong.
Analysis of risk factors and attributable disease burden of four major chronic diseases including cancer in the Chinese population
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 442-447.
|
[8] |
SU Lili, LAN Zhenyu, LIN Huizhe, YAN Fangna, CHEN Weilian, LIN Wei.
Effects of sarcopenia on prognosis of prostate cancer treatment: a Meta-analysis
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 487-493.
|
[9] |
YAN Haiqing, LAI Qinqiao, WU Liucheng, WANG Ting'an, XIA Xiang, HUANG Mingwei, QIN Yuzhou.
Effects of SH3BGRL on proliferation and migration of gastric cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 285-294.
|
[10] |
SUN Xiaoxia, WANG Yuping, SI Meili, ZHU Jing, ZHONG Mei.
Trends of incidence and mortality and the age-period-cohort of cervical cancer in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 317-320.
|
[11] |
QIN Liming, ZHOU Zihan, CAO Ji, LI Qiulin, YU Jiahua, RONG Minhua, ZHAO Libin, MAI Yuejiao, GE Lianying, QIN Yuzhou, YU Hongping.
Epidemiological characteristics and disease burden analysis of gastric cancer in Guangxi,2011—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 172-178.
|
[12] |
WANG Juwei, WANG Jing, MA Lijun, LI Zan .
Trends in the incidence and mortality of liver cancer in China based on the JoinPoint regression model,2000—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 180-185.
|
[13] |
NIU Shengli, LIU Bowei.
Effects of high sodium diet on the burden of gastric cancer in Chinese residents and a trend analysis,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 186-192.
|
[14] |
MA Fuchao, LIU Aiquan, XIE Weishun, SHEN Yanhua, FENG Jie, JIANG Qi, GE Lianying.
Screening and diagnostic efficacy evaluation of risk miRNAs during the development of gastric cancer: a multicenter study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 193-199.
|
[15] |
ZHOU Zihan, LI Qiulin, YU Jiahua, RONG Minhua, CAO Ji, GE Lianying, TANG Weizhong, YU Hongping.
Analysis of the epidemiological characteristics and disease burden of malignant tumors in Guangxi, 2019#br#
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 67-.
|